Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially serious adverse effect of a wide range of chemotherapeutics. The lack of understanding of the molecular mechanisms underlying CIPN limits the efficacy of chemotherapy and development of therapeutics for treatment and preve...

Full description

Bibliographic Details
Main Authors: Christina Mortensen, Nanna Elman Andersen, Tore Bjerregaard Stage
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/16/3939
_version_ 1797410947377135616
author Christina Mortensen
Nanna Elman Andersen
Tore Bjerregaard Stage
author_facet Christina Mortensen
Nanna Elman Andersen
Tore Bjerregaard Stage
author_sort Christina Mortensen
collection DOAJ
description Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially serious adverse effect of a wide range of chemotherapeutics. The lack of understanding of the molecular mechanisms underlying CIPN limits the efficacy of chemotherapy and development of therapeutics for treatment and prevention of CIPN. Human induced pluripotent stem cells (iPSCs) have become an important tool to generate the cell types associated with CIPN symptoms in cancer patients. We reviewed the literature for iPSC-derived models that assessed neurotoxicity among chemotherapeutics associated with CIPN. Furthermore, we discuss the gaps in our current knowledge and provide guidance for selecting clinically relevant concentrations of chemotherapy for in vitro studies. Studies in iPSC-derived neurons revealed differential sensitivity towards mechanistically diverse chemotherapeutics associated with CIPN. Additionally, the sensitivity to chemotherapy was determined by donor background and whether the neurons had a central or peripheral nervous system identity. We propose to utilize clinically relevant concentrations that reflect the free, unbound fraction of chemotherapeutics in plasma in future studies. In conclusion, iPSC-derived sensory neurons are a valuable model to assess CIPN; however, studies in Schwann cells and motor neurons are warranted. The inclusion of multiple iPSC donors and concentrations of chemotherapy known to be achievable in patients can potentially improve translational success.
first_indexed 2024-03-09T04:37:53Z
format Article
id doaj.art-35c5cbd14f334fa4ae7791d0d664a1df
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T04:37:53Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-35c5cbd14f334fa4ae7791d0d664a1df2023-12-03T13:25:04ZengMDPI AGCancers2072-66942022-08-011416393910.3390/cancers14163939Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based ModelingChristina Mortensen0Nanna Elman Andersen1Tore Bjerregaard Stage2Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, DK-5000 Odense C, DenmarkClinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, DK-5000 Odense C, DenmarkClinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, DK-5000 Odense C, DenmarkChemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially serious adverse effect of a wide range of chemotherapeutics. The lack of understanding of the molecular mechanisms underlying CIPN limits the efficacy of chemotherapy and development of therapeutics for treatment and prevention of CIPN. Human induced pluripotent stem cells (iPSCs) have become an important tool to generate the cell types associated with CIPN symptoms in cancer patients. We reviewed the literature for iPSC-derived models that assessed neurotoxicity among chemotherapeutics associated with CIPN. Furthermore, we discuss the gaps in our current knowledge and provide guidance for selecting clinically relevant concentrations of chemotherapy for in vitro studies. Studies in iPSC-derived neurons revealed differential sensitivity towards mechanistically diverse chemotherapeutics associated with CIPN. Additionally, the sensitivity to chemotherapy was determined by donor background and whether the neurons had a central or peripheral nervous system identity. We propose to utilize clinically relevant concentrations that reflect the free, unbound fraction of chemotherapeutics in plasma in future studies. In conclusion, iPSC-derived sensory neurons are a valuable model to assess CIPN; however, studies in Schwann cells and motor neurons are warranted. The inclusion of multiple iPSC donors and concentrations of chemotherapy known to be achievable in patients can potentially improve translational success.https://www.mdpi.com/2072-6694/14/16/3939chemotherapy-induced peripheral neuropathyinduced pluripotent stem cellsdorsal root gangliasensory neuronsSchwann cellsin vitro cell models
spellingShingle Christina Mortensen
Nanna Elman Andersen
Tore Bjerregaard Stage
Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling
Cancers
chemotherapy-induced peripheral neuropathy
induced pluripotent stem cells
dorsal root ganglia
sensory neurons
Schwann cells
in vitro cell models
title Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling
title_full Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling
title_fullStr Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling
title_full_unstemmed Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling
title_short Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling
title_sort bridging the translational gap in chemotherapy induced peripheral neuropathy with ipsc based modeling
topic chemotherapy-induced peripheral neuropathy
induced pluripotent stem cells
dorsal root ganglia
sensory neurons
Schwann cells
in vitro cell models
url https://www.mdpi.com/2072-6694/14/16/3939
work_keys_str_mv AT christinamortensen bridgingthetranslationalgapinchemotherapyinducedperipheralneuropathywithipscbasedmodeling
AT nannaelmanandersen bridgingthetranslationalgapinchemotherapyinducedperipheralneuropathywithipscbasedmodeling
AT torebjerregaardstage bridgingthetranslationalgapinchemotherapyinducedperipheralneuropathywithipscbasedmodeling